Clinical Trial to Evaluate the Efficacy and Safety of Suvaro®OD Tablet in Patients With Dyslipidemia
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 112 participants.
Also called NCT06153433
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 112 participants
- Sponsor
- Registry
-
NCT06153433
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- South Korea
- Registry status
- Unknown status
Technical summary
Registry record NCT06153433. Randomized; no masking; primary purpose treatment. Start 2023-11-06 (actual); primary completion 2024-07 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Clinical Trial to Evaluate the Efficacy and Safety of Suvaro®OD Tablet in Patients With Dyslipidemia
- Condition
- Dyslipidemia
- Intervention (Drug)
- Rosuvastatin Immediate-Release Tablet (IRT) 10mg
- Intervention (Drug)
- Rosuvastatin orally disintegrating tablet (SUVARO®ODT) 10mg
- Lead sponsor
- Yonsei University
Record details
- Record id
cardio:ct-nct06153433- Content hash
de004041c0992297c1ffaa756e6bafa826b9f710363f886f8f8cb9b57bba3d55